Your browser doesn't support javascript.
loading
ON-Target Adverse Events of CRISPR-Cas9 Nuclease: More Chaotic than Expected.
Boutin, Julian; Cappellen, David; Rosier, Juliette; Amintas, Samuel; Dabernat, Sandrine; Bedel, Aurélie; Moreau-Gaudry, François.
Affiliation
  • Boutin J; Bordeaux University, Bordeaux, France.
  • Cappellen D; INSERM U1035, Biotherapy of Genetic Diseases, Inflammatory Disorders and Cancers, Bordeaux, France.
  • Rosier J; Biochemistry Laboratory, University Hospital Bordeaux, Bordeaux, France.
  • Amintas S; Bordeaux University, Bordeaux, France.
  • Dabernat S; INSERM U1035, Biotherapy of Genetic Diseases, Inflammatory Disorders and Cancers, Bordeaux, France.
  • Bedel A; Tumor Biology and Tumor Bank Laboratory, University Hospital Bordeaux, Bordeaux, France.
  • Moreau-Gaudry F; Bordeaux University, Bordeaux, France.
CRISPR J ; 5(1): 19-30, 2022 02.
Article in En | MEDLINE | ID: mdl-35099280
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: CRISPR-Cas Systems / Gene Editing Type of study: Prognostic_studies Language: En Journal: CRISPR J Year: 2022 Document type: Article Affiliation country: Francia Country of publication: Estados Unidos
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: CRISPR-Cas Systems / Gene Editing Type of study: Prognostic_studies Language: En Journal: CRISPR J Year: 2022 Document type: Article Affiliation country: Francia Country of publication: Estados Unidos